BLINATUMOMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY B-ACUTE LYMPHOBLASTIC LEUKEMIA: REPORT FROM A SINGLE CENTER

被引:0
|
作者
Giammarco, S. [1 ]
Chiusolo, P. [2 ]
Metafuni, E. [1 ]
Sora, F. [2 ]
Laurenti, L. [2 ]
Innocenti, I. [1 ]
Autore, F. [1 ]
Bacigalupo, A. [2 ]
Sica, S. [2 ]
机构
[1] IRCCS, Fdn Policlin Univ A Gemelli, Rome, Italy
[2] Univ Cattolica Sacro Cuore, IRCCS, Milan, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PU12
引用
收藏
页码:158 / 159
页数:2
相关论文
共 50 条
  • [31] Low leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia
    Queudeville, Manon
    Stein, Anthony S.
    Locatelli, Franco
    Ebinger, Martin
    Handgretinger, Rupert
    Goekbuget, Nicola
    Gore, Lia
    Zeng, Yi
    Gokani, Priya
    Zugmaier, Gerhard
    Kantarjian, Hagop M.
    CANCER, 2023, 129 (09) : 1384 - 1393
  • [32] Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
    Kantarjian, Hagop M.
    Zugmaier, Gerhard
    Brueggemann, Monika
    Wood, Brent L.
    Horst, Heinz A.
    Zeng, Yi
    Martinelli, Giovanni
    CANCERS, 2021, 13 (22)
  • [33] Selecting the optimal targeted therapy for relapsed B-acute lymphoblastic leukemia
    Fulcher, Jill
    Leung, Eugene
    Christou, Grace
    Bredeson, Christopher
    Sabloff, Mitchell
    LEUKEMIA & LYMPHOMA, 2020, 61 (09) : 2271 - 2273
  • [34] Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies
    Kantarjian, Hagop M.
    Stein, Anthony S.
    Bargou, Ralf C.
    Grande Garcia, Carlos
    Larson, Richard A.
    Stelljes, Matthias
    Goekbuget, Nicola
    Zugmaier, Gerhard
    Benjamin, Jonathan E.
    Zhang, Alicia
    Jia, Catherine
    Topp, Max S.
    CANCER, 2016, 122 (14) : 2178 - 2185
  • [35] Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
    Goekbuget, N.
    Kelsh, M.
    Chia, V.
    Advani, A.
    Bassan, R.
    Dombret, H.
    Doubek, M.
    Fielding, A. K.
    Giebel, S.
    Haddad, V.
    Hoelzer, D.
    Holland, C.
    Ifrah, N.
    Katz, A.
    Maniar, T.
    Martinelli, G.
    Morgades, M.
    O'Brien, S.
    Ribera, J-M
    Rowe, J. M.
    Stein, A.
    Topp, M.
    Wadleigh, M.
    Kantarjian, H.
    BLOOD CANCER JOURNAL, 2016, 6 : e473 - e473
  • [36] Correlates of resistance and relapse during blinatumomab therapy for relapsed/refractory acute lymphoblastic leukemia
    Aldoss, Ibrahim
    Song, Joo
    Stiller, Tracey
    Nguyen, Tina
    Palmer, Joycelynne
    O'Donnell, Margaret
    Stein, Anthony S.
    Marcucci, Guido
    Forman, Stephen
    Pullarkat, Vinod
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (09) : 858 - 865
  • [37] Blinatumomab Pharmacodynamics and Exposure-Response Relationships in Relapsed/Refractory Acute Lymphoblastic Leukemia
    Zhu, Min
    Kratzer, Andrea
    Johnson, Jessica
    Holland, Chris
    Brandl, Christian
    Singh, Indrajeet
    Wolf, Andreas
    Doshi, Sameer
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (02): : 168 - 179
  • [38] Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date
    Hathaway, Lindsey
    Sen, Jeremy Michael
    Keng, Michael
    PATIENT-RELATED OUTCOME MEASURES, 2018, 9 : 329 - 337
  • [39] Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
    N Gökbuget
    M Kelsh
    V Chia
    A Advani
    R Bassan
    H Dombret
    M Doubek
    A K Fielding
    S Giebel
    V Haddad
    D Hoelzer
    C Holland
    N Ifrah
    A Katz
    T Maniar
    G Martinelli
    M Morgades
    S O'Brien
    J-M Ribera
    J M Rowe
    A Stein
    M Topp
    M Wadleigh
    H Kantarjian
    Blood Cancer Journal, 2016, 6 : e473 - e473
  • [40] Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults
    Aharon Ronson
    Ariella Tvito
    Jacob M. Rowe
    Current Oncology Reports, 2016, 18